Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123313) titled 'Clinical study of 68Ga-labeled epidermal growth factor receptor variant III mutant molecular probe (68Ga-PAGA) in glioma imaging' on April 23.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Huashan Hospital, Fudan University

Condition: glioma

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2023-10-28

Target Sample Size: Test group:9;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=316310

Disclaimer: Curated by HT Syndication....